Related Experiment Video
Updated: May 27, 2025
08:19
Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications
Published on: November 17, 2015
17.1K
Advances in Lipid Nanoparticle-Based Disease Treatment
Yujie Zhou1, Qiqi Ge1, Xin Wang1
1School of Pharmacy, Changzhou University, Changzhou, Jiangsu, China (Jianhao Wang), (Cheng Wang.
Chemmedchem
|February 18, 2025
Summary
Lipid nanoparticles (LNPs) offer advanced drug delivery for various diseases, including cancer and genetic disorders. Ongoing research aims to overcome manufacturing and stability challenges for next-generation therapeutics.
Area of Science:
- Biotechnology
- Nanomedicine
- Drug Delivery Systems
Background:
- Lipid nanoparticles (LNPs) have evolved from early liposomes to overcome drug delivery limitations.
- Advancements address poor bioavailability, off-target effects, and instability for enhanced therapeutic efficacy and safety.
Purpose of the Study:
- To review the latest advancements in LNP technology and their diverse clinical applications.
- To highlight LNP applications in cancer, gene therapy, infectious diseases, and glaucoma.
Main Methods:
- Review of recent studies on LNP applications in various therapeutic areas.
- Focus on LNP-mediated delivery of messenger RNA (mRNA) and small interfering RNA (siRNA).
- Examination of LNP roles in RNA interference and CRISPR-Cas9 genome editing.
Main Results:
- LNPs demonstrate significant potential in precise genetic interventions and treating acute/chronic disorders.
- Successful applications noted in cancer therapy, gene therapy, and infectious disease management.
- LNPs show versatility in ameliorating various medical conditions.
Conclusions:
- LNPs are a transformative platform for targeted therapeutic delivery, revolutionizing treatment paradigms.
- Challenges in large-scale manufacturing, stability, and safety evaluations require further research.
- Future directions include formulation optimization, combination therapies, and personalized medicine integration.
